There is no website visitor data available for this stock.
---
FNCH FAQ
What was Finch Therapeutics Group’s price range in the past 12 months?
Finch Therapeutics Group lowest stock price was $0.80 and its highest was $9.42 in the past 12 months.
What is Finch Therapeutics Group’s market cap?
Currently, no data Available
When is Finch Therapeutics Group’s upcoming earnings report date?
Finch Therapeutics Group’s upcoming earnings report date is May 09, 2024 which is 73 days ago.
How were Finch Therapeutics Group’s earnings last quarter?
Finch Therapeutics Group released its earnings results on Mar 28, 2024. The company reported -$1.894 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.894.
Finch Therapeutics Group does not currently pay dividends.
What is Finch Therapeutics Group’s EPS estimate?
Finch Therapeutics Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Finch Therapeutics Group have?
Finch Therapeutics Group has 1,605,763 shares outstanding.
What happened to Finch Therapeutics Group’s price movement after its last earnings report?
Finch Therapeutics Group reported an EPS of -$1.894 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.245%.
Which hedge fund is a major shareholder of Finch Therapeutics Group?
Among the largest hedge funds holding Finch Therapeutics Group’s share is Baupost Group LLC. It holds Finch Therapeutics Group’s shares valued at N/A.
Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs. It is developing novel therapeutics to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The lead product candidate is CP101 which delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection.
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -82.64% per trade.